All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10295612" target="_blank" >RIV/00216208:11110/15:10295612 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/15:10295612

  • Result on the web

    <a href="http://dx.doi.org/10.1111/ene.12716" target="_blank" >http://dx.doi.org/10.1111/ene.12716</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/ene.12716" target="_blank" >10.1111/ene.12716</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Early magnetic resonance imaging predictors of clinical progression after 48months in clinically isolated syndrome patients treated with intramuscular interferon beta-1a

  • Original language description

    Background and purposeOur aim was to identify early imaging surrogate markers of clinical progression in patients after the first demyelinating event suggestive of multiple sclerosis treated with weekly intramuscular interferon -1a. In a prospective observational study, the predictive role of baseline and 6-month changes in magnetic resonance imaging outcomes was investigated with respect to relapse activity and development of confirmed disability progression in patients after 48months. MethodsThis study examined 210 patients. Multivariate Cox proportional hazard models were used to analyse predictors of relapse activity and confirmed disability progression after 48months. ResultsGreater T2 lesion volume [hazard ratio (HR) 1.81; P=0.005] and the presence of contrast-enhancing lesions (HR 2.13; P<0.001) at baseline were significantly associated with increased cumulative risk of a second clinical attack over 48months. A greater decrease of the corpus callosum volume (HR 2.74; P=0.001) an

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD branch

Result continuities

  • Project

    <a href="/en/project/NT13237" target="_blank" >NT13237: Clinical and paraclinical markers of multiple sclerosis – description and prediction of disease activity</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    European Journal of Neurology

  • ISSN

    1351-5101

  • e-ISSN

  • Volume of the periodical

    22

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    11

  • Pages from-to

    1113-1123

  • UT code for WoS article

    000356090800014

  • EID of the result in the Scopus database

    2-s2.0-84930758628